Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oxford Immunotec Global PLC (NASDAQ:OXFD)

14.14
Delayed Data
As of 10:08am ET
 -0.23 / -1.60%
Today’s Change
10.01
Today|||52-Week Range
15.61
+3.82%
Year-to-Date
No recent news for Oxford Immunotec Global PLC.

Today’s Trading

Previous close14.37
Today’s open14.08
Day’s range14.08 - 14.36
Volume2,343
Average volume (3 months)59,131
Market cap$323.8M
Dividend yield--
Data as of 10:08am ET, 09/01/2015

Growth & Valuation

Earnings growth (last year)+43.36%
Earnings growth (this year)+8.86%
Earnings growth (next 5 years)--
Revenue growth (last year)+27.64%
P/E ratio--
Price/Sales4.76
Price/Book4.18

Competitors

 Today’s
change
Today’s
% change
BDSIBioDelivery Sciences...-0.14-2.07%
TRIBTrinity Biotech PLC-0.36-2.34%
QTNTQuotient Ltd-0.05-0.30%
VCYTVeracyte Inc-0.08-0.85%
Data as of 10:21am ET, 09/01/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$49.5M
Annual profit (last year)-$22.2M
Net profit margin-44.79%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Peter James Wrighton-Smith
Chief Operations Officer
Peter Edwardson
Corporate headquarters
Abingdon, Oxfordshire

Forecasts

Partner Offers